Superactive somatostatin analog decreases plasma glucose and glucagon levels in diabetic rats

This publication has 13 references indexed in Scilit:

• Effects of highly potent octapeptide analogs of somatostatin on growth hormone, insulin and glucagon release
  Life Sciences, 1987
• Somatostatin Analog SMS 201-995 and Insulin Needs in Insulin-Dependent Diabetic Patients Studied by Means of an Artificial Pancreas*
  Journal of Clinical Endocrinology & Metabolism, 1986
• Efficacy, pharmacokinetics and tolerability of a somatostatin analogue (L-363, 586) in insulin-dependent diabetes mellitus
  Life Sciences, 1986
• Effect of Twice Daily Subcutaneous Administration of a Long-Acting Somatostatin Analog on 24-Hour Plasma Glucose Profiles in Patients with Insulin-Dependent Diabetes Mellitus
  Hormone and Metabolic Research, 1985
• Effects of a long-acting somatostatin analogue on postprandial hyperglycemia in insulin-dependent diabetes mellitus
  Metabolism, 1983
• Insulin-Glucagon Relationships in the Defense Against Hypoglycemia
  Diabetes, 1983
• Lack of glucagon response in glucose counter-regulation in Type 1 (insulin-dependent) diabetics: Absence of recovery after prolonged optimal insulin therapy
  Diabetologia, 1982
• Treatment of Streptozotocin-Diabetic Dogs With a Long-Acting Somatostatin Analog
  Diabetes, 1979
• Clinical evaluation of somatostatin as a potential adjunct to insulin in the management of diabetes mellitus
  Diabetologia, 1977
• The role of glucagon-insulin interactions in control of glucose turnover and its significance in diabetes
  Metabolism, 1976